Does MIRABEGRON Cause Hypercholesterolaemia? 432 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 432 reports of Hypercholesterolaemia have been filed in association with MIRABEGRON (MIRABEGRON). This represents 2.1% of all adverse event reports for MIRABEGRON.
432
Reports of Hypercholesterolaemia with MIRABEGRON
2.1%
of all MIRABEGRON reports
430
Deaths
348
Hospitalizations
How Dangerous Is Hypercholesterolaemia From MIRABEGRON?
Of the 432 reports, 430 (99.5%) resulted in death, 348 (80.6%) required hospitalization, and 362 (83.8%) were considered life-threatening.
Is Hypercholesterolaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MIRABEGRON. However, 432 reports have been filed with the FAERS database.
What Other Side Effects Does MIRABEGRON Cause?
Drug ineffective (4,151)
Off label use (1,704)
Intentional product misuse (1,416)
Dizziness (1,297)
Headache (1,288)
Blood pressure increased (1,100)
Hypertension (1,057)
Dry mouth (1,034)
Diarrhoea (921)
Pain (921)
What Other Drugs Cause Hypercholesterolaemia?
ALENDRONATE (1,607)
METHOTREXATE (1,547)
TOCILIZUMAB (1,483)
ADALIMUMAB (1,479)
ABATACEPT (1,410)
RITUXIMAB (1,389)
PREDNISONE (1,377)
INFLIXIMAB (1,338)
DICLOFENAC (1,331)
LEFLUNOMIDE (1,322)
Which MIRABEGRON Alternatives Have Lower Hypercholesterolaemia Risk?
MIRABEGRON vs MIRALAX
MIRABEGRON vs MIRCERA
MIRABEGRON vs MIRENA
MIRABEGRON vs MIRIKIZUMAB-MRKZ
MIRABEGRON vs MIRTAZAPINE